University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine ...

US-based PharmaJet, a company dedicated to enhancing injectable performance through needle-free injection technology, has ...

Currently, IPV is relatively expensive to produce because it requires high levels of bio-containment to minimise the risk of leaks of live poliovirus, which could result in outbreaks. VLPs are ...

Uttarakhand High Court acquitted a polio-affected man convicted of rape and ordered the state government to compensate him ...

Polio has emerged as a major challenge in Pakistan. It is not simply a challenge in the health sector, but has also become ...

Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...

A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

Scientists have developed a vaccine using virus-like particles (VLPs), which mimic the poliovirus but do not contain any ...

The eradication of polio as a global health threat may be delayed unless U.S. funding cuts – potentially totaling hundreds of ...

Here are some of the 5,800 contracts the Trump administration formally canceled this week in a wave of terse emails.

Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).